STOCKHOLM, SWEDEN / ACCESSWIRE / December 29, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) Promore Pharma AB, under change of name to…
STOCKHOLM, SWEDEN / ACCESSWIRE / December 29, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") announces today that…
FORT MYERS, FL / ACCESSWIRE / December 28, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading oncology testing services…
Company adds further expertise in medical device industry R&D, regulatory affairs and commercializationMINNEAPOLIS, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Inspire…
- Company’s co-development partner, Giiant Pharma, Inc. (“Giiant”), receives funding as part of previously announced grant from the US Crohn’s…
Awarded additional $6.7 million to advance NexoBrid as a non-surgical field care solution; R&D project budget increased to $14.4 millionYAVNE,…
WALTHAM, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a…
SEATTLE, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…
In 2023, Cosmos Health concluded multiple acquisitions, including Cana Laboratories, the distribution network owned by Bikas GP, and ZipDoctor.These acquisitions…
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV)…